Isoneochamaejasmin A

CAS No. 871319-96-9

Isoneochamaejasmin A( —— )

Catalog No. M29382 CAS No. 871319-96-9

Isoneochamaejasmin A (INCA), a biflavonoid, is one of main active ingredients in the dried root of Stellera chamaejasme L., a widely used traditional Chinese medicine.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 567 Get Quote
10MG 807 Get Quote
25MG 1215 Get Quote
50MG 1638 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Isoneochamaejasmin A
  • Note
    Research use only, not for human use.
  • Brief Description
    Isoneochamaejasmin A (INCA), a biflavonoid, is one of main active ingredients in the dried root of Stellera chamaejasme L., a widely used traditional Chinese medicine.
  • Description
    Isoneochamaejasmin A (INCA), a biflavonoid, is one of main active ingredients in the dried root of Stellera chamaejasme L., a widely used traditional Chinese medicine.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    871319-96-9
  • Formula Weight
    542.49
  • Molecular Formula
    C30H22O10
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Oc1ccc([C@@H]([C@@H]([C@@H]([C@@H](c(cc2)ccc2O)Oc2c3c(O)cc(O)c2)C3=O)C2=O)Oc3c2c(O)cc(O)c3)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Viquidil hydrochlori...

    Viquidil hydrochloride is an isomer of Quinidine. Viquidil hydrochloride is an agent of cerebral vasodilator with antithrombotic activity.

  • CRT-0105950

    CRT-0105950 is a potent LIMK inhibitor with high affinity for both LIMK1 and LIMK2.CRT-0105950 inhibits filamentous cutin phosphorylation and promotes α-microtubulin acetylation in cells.

  • Mupadolimab

    Mupadolimab (CPI-006) is a humanized FC-γR binding deficient IgG1 anti-CD73 antibody with potential anticancer activity and activation of CD73POS B cells.